First Time Loading...

Opthea Ltd
ASX:OPT

Watchlist Manager
Opthea Ltd Logo
Opthea Ltd
ASX:OPT
Watchlist
Price: 0.61 AUD -1.61% Market Closed
Updated: May 2, 2024

Wall Street
Price Targets

OPT Price Targets Summary
Opthea Ltd

There are no price targets for OPT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Opthea Ltd Competitors:
Price Targets
AMGN
Amgen Inc
13% Upside
MRKR
Marker Therapeutics Inc
210% Upside
IMTX
Immatics NV
77% Upside
4974
Takara Bio Inc
102% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
38% Upside
BAVA
Bavarian Nordic A/S
82% Upside
RCUS
Arcus Biosciences Inc
158% Upside
HRTX
Heron Therapeutics Inc
205% Upside

Revenue
Forecast

Revenue Estimate
Opthea Ltd

For the last 8 years the compound annual growth rate for Opthea Ltd's revenue is -24%. The projected CAGR for the next 3 years is 13%.

-24%
Past Growth
13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Opthea Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

Net Income Estimate
Opthea Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
61%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPT's stock price target?
Not Available

OPT doesn't have any price targets made by Wall Street professionals.

What is Opthea Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Opthea Ltd's revenue is -24%. The projected CAGR for the next 3 years is 13%.